News

Filter

Current filters:

Express Scripts

Report: US state governments may spend $55 billion on hepatitis C drugs

Report: US state governments may spend $55 billion on hepatitis C drugs

17-07-2014

State legislatures in the USA will need to find billions in their budgets to purchase costly new hepatitis…

Anti-viralsExpress ScriptsFinancialGilead SciencesHealthcarePharmaceuticalSovaldiUSA

Express Scripts faces three subpoenas over dealings with drugmakers

01-05-2014

US pharmacy benefits manager Express Scripts has revealed that it has received three government subpoenas…

Attorney GeneralBenefits managerBusiness FinanceExpress ScriptsLaw CrimeLegalManager ExpressPharmaceuticalUSA

Express Scripts adds Vivus' Qsymia to its standard benefits program

20-12-2012

US drugmaker Vivus (Nasdaq: VVUS) says that Express Scripts, among the USA's largest Pharmacy Benefit…

Express ScriptsMarkets & MarketingMetabolicsNorth AmericaPharmaceuticalQsymiaVivus

Strong start for Vivus' obesity drug Qsymia; deal with Express Scripts

10-10-2012

Sales of US drugmaker Vivus' (Nasdaq: VVUS) obesity agent Qsymia (phentermine and topiramate extended-release)…

Express ScriptsMarkets & MarketingMetabolicsNorth AmericaPharmaceuticalQsymiaVivus

Flaws in ESI/Medco efficiency claims exposed

20-02-2012

David Balto, an antitrust attorney in Washington DC, USA, and former Policy Director of the Federal Trade…

Express ScriptsLegalMedcoMergers & AcquisitionsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top